Nearly 77 percent of pulmonary clinical trials failed to report race and ethnicity data

Researchers from Duke University and Durham Veteran Affairs Medical Center have found that nearly 77 percent of pulmonary clinical trials registered with ClinicalTrials.gov failed to report race and ethnicity data, and biologic-related studies had even lower odds of reporting race and ethnicity data when compared with drug trials.

The researchers employed a validated algorithm and assessed clinical trials in pulmonary medicine between 2008-2012 and examined race and ethnicity reporting through September 2013. Researchers discovered that trials completed more recently were more likely to report the data compared with earlier trials, and trials studying asthma and COPD had significantly greater odds of reporting race and ethnicity when compared with other pulmonary trials.

"Our study highlights a need to increase and encourage race and ethnicity reporting among pulmonary trials. This reporting could help clarify treatment effects among ethnic and ," said Dr. Isaretta L. Riley, Duke University and lead researcher, "we're encouraged by the trend of more recent trials reporting this data but recognize there is still opportunity for improvement."


Explore further

Study raises concerns about reporting of noninferiority trials

More information: Additional results will be shared on Monday, October 26, at 4:30 pm at Palais des congrès de Montréal, room 513ef.
Citation: Nearly 77 percent of pulmonary clinical trials failed to report race and ethnicity data (2015, October 19) retrieved 28 February 2020 from https://medicalxpress.com/news/2015-10-percent-pulmonary-clinical-trials-ethnicity.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments